Chronic Pain Clinical Trial
Official title:
The Effects of Water Temperature on the Cold Pressor Test in Patients With Opioid-Induced Hyperalgesia in Comparison to Healthy Controls
This current study is intended to be completed under the umbrella of the current GHUCCTS IRB- approved study "Opioid-Induced Hyperalgesia In Prescription Opioid Abusers: Effects of Pregabalin" (Lyrica study) (PRO00000669). In this proposed study, 10 healthy male, 10 healthy female participants and 5 male, 5 female OIH participants (from the parent Lyrica study), who are prescription opioid abusers with chronic pain currently taking Suboxone, will be asked to take the cold pressor test at 1, 5, and 9 degrees Celsius and to report the time at which pain has completely gone away following each test. The purpose of this study is to examine how the water temperature of the cold pressure test might affect the participants' response (i.e., the participants pain threshold and pain tolerance) and to see if there is a difference in how each participation group is affected.
Since the 1940s, the cold pressor test (CPT) has been used experimentally as a pain
induction method due to its reliability, cost effectiveness and minimal production of side
effects. In the CPT, a patient is asked to place his or her hand and forearm in an ice bath
until the pain is too great to remain in the water. Researchers have employed the CPT to
test a wide range of pain management techniques, including medications, cognitive- based
therapies, or acupuncture, as well as to explore pain perception. The CPT has been performed
on a variety of participants, including adolescents, drug abusers, and those suffering from
chronic back pain.
In their classic 1989 paper, Walsh and colleagues developed the normative model of the CPT
demonstrating that variations in response are dependent upon age, sex and ethnicity. In
2004, however, Mitchell et al. discovered that the water temperature of the CPT also plays a
crucial role in the pain tolerance time of the subjects, noting that a temperature variation
of 4°C produced significantly different results for the same subject. While the Mitchell
investigations improved upon the standard for the proper CPT technique, as seen implemented
in the works of Rash and Campbell, their discoveries were based on healthy individuals.
Researchers have explored the CPT responses of patients with an altered pain perception,
such as patients with Opioid-Induced Hyperalgesia (OIH), in comparison to healthy controls,
demonstrating greater sensitivity in OIH patients. What has not been studied is the effect
of temperature on CPT response in OIH patients. Further, the CPT has been shown to have a
relatively lengthy recovery time averaging around 10 minutes; however, the recovery time for
hypersensitive patients, such as OIH patients, has yet to be studied.
As an extension of the work of Mitchell and colleagues, the proposed research will assess
the effects of temperature difference and recovery time of the CPT on patients with OIH in
comparison to healthy normal control patients. This work is a sub-study of a larger study,
Opioid-Induced Hyperalgesia In Prescription Opioid Abusers: Effects of Pregabalin
(PRO00000669), conducted by principal investigator Dr. Peggy Compton. The goal of the parent
study is to evaluate the ability of pregabalin to diminish chronic low back or arthritic
pain and OIH in a sample of prescription opioid abusers (POAs) opioid therapy. This current
study is not assigning specific interventions to study subjects. Healthy control and OIH
participants will complete all study measures in a single two-hour study session.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|